Slow Release Formulations of Inhaled Rifampin

Journal Title: The AAPS Journal - Year 2008, Vol 10, Issue 2

Abstract

Rifampin microspheres were prepared by spray drying using either polylactic acid (PLA) or poly(lactic-co-glycolic acid) (PLGA) polymers in different drug to polymer ratios (90:10 to 5:95, w/w). The in-vitro release characteristics, particle-size distribution, and cytotoxicity (in an alveolar macrophage cell line) and pharmacokinetics in rats after pulmonary instillation were evaluated. Increasing the polymer content from 10% to 95% slowed down the in vitro drug release with PLGA particles showing a steeper change with increasing polymer content (100% to 20% drug release over 6 h) than PLA particles (88% to 42% drug release over 6 h). PLA microsphere formulations revealed lack of cytotoxicity and a mass median aerodynamic diameter (MMDA) of 2.22–2.86 μm, while PLGA particles were larger (MMDA of 4.67–5.11 μm). Pharmacokinetics differed among the formulations with the 10% PLA formulation showing a distinct sustained release (tmax of 2 h vs 0.5 h of free drug) and a systemic bioavailability similar to that of free drug. Formulations with high polymer content showed a lower relative bioavailability (30%). This suggested that an optimal release rate existed for which a distinct amount of drug was delivered over an extended period of time.

Authors and Affiliations

Intira Coowanitwong, Vikram Arya, Poj Kulvanich, Günther Hochhaus

Keywords

Related Articles

Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation

This review covers reports published in the last 5 years on the anti-inflammatory activities of all classes of cannabinoids, including phytocannabinoids such as tetrahydrocannabinol and cannabidiol, synthetic ana...

Comparison of the formulation requirements of dosator and dosing disc automatic capsule filling machines

The overall objective of this study was to provide ‘semi-quantitative’ or ‘rigorous’ definitions of the fluidity, lubricity and compactibility requirements of formulation for representativ...

Controlled Crystallization of the Lipophilic Drug Fenofibrate During Freeze-Drying: Elucidation of the Mechanism by In-Line Raman Spectroscopy

We developed a novel process, “controlled crystallization during freeze-drying” to produce drug nanocrystals of poorly water-soluble drugs. This process involves freeze-drying at a relatively high tempera...

Recent progress in the computational prediction of aqueous solubility and absorption

The computational prediction of aqueous solubility and/or human absorption has been the goal of many researchers in recent years. Such anin silico counterpart to the biopharmaceutical classification system (BCS) would ha...

Pharmacokinetic mAb–mAb Interaction: Anti-VEGF mAb Decreases the Distribution of Anti-CEA mAb into Colorectal Tumor Xenografts

To date, there has been little investigation of the risk for drug–drug interactions involving monoclonal antibodies. The present work examined the effects of an anti-vascular endothelial growth factor (anti-VEGF)...

Download PDF file
  • EP ID EP681551
  • DOI  10.1208/s12248-008-9044-5
  • Views 50
  • Downloads 0

How To Cite

Intira Coowanitwong, Vikram Arya, Poj Kulvanich, Günther Hochhaus (2008). Slow Release Formulations of Inhaled Rifampin. The AAPS Journal, 10(2), -. https://europub.co.uk/articles/-A-681551